Home  /  Resource Library  /  Axi-Cel Treatment Outcomes Correlate With Response to Prior Therapy in Refractory Large B-Cell Lymphoma

Axi-Cel Treatment Outcomes Correlate With Response to Prior Therapy in Refractory Large B-Cell Lymphoma

Transplantation and Cellular Therapy 2021: Retrospective study examined the association between response to CAR T therapy axicabtagene ciloleucel and response to previous lines of therapy in patients with relapsed DLBCL.